Secured Research | Equipment Finance Originator | Monitor | Monitor Suite | Converge | STRIPES Leadership
No Result
View All Result
ABF Journal
Forward for Specialty Finance
SUBSCRIBE
Lender & Services Directory
  • News
    • People
    • Economy
    • All News
  • Deals
  • Magazine
    • Magazine Issues
    • Nominations
  • Features
    • Articles & Insights
    • Resolving MCA Distress
    • Resolving Business Distress
  • Events
  • Recruiting
    • Molloy Associates Senior Asset Based Lending Originator Location: Remote
  • Advertise
    • Advertise for 2027
  • Contact Us
  • News
    • People
    • Economy
    • All News
  • Deals
  • Magazine
    • Magazine Issues
    • Nominations
  • Features
    • Articles & Insights
    • Resolving MCA Distress
    • Resolving Business Distress
  • Events
  • Recruiting
    • Molloy Associates Senior Asset Based Lending Originator Location: Remote
  • Advertise
    • Advertise for 2027
  • Contact Us
No Result
View All Result
ABF Journal
No Result
View All Result
Home Deal Announcements

Myriad Genetics Closes $200MM Credit Facility from OrbiMed

The facility, provided by OrbiMed, includes $125 million of funded capital with an option to borrow up to an additional $75 million until June 30, 2027.

byBrianna Wilson
August 3, 2025
in Deal Announcements, News

Myriad Genetics, a company in molecular diagnostic testing and precision medicine, closed a five-year senior secured term loan credit facility providing up to $200 million of capital from OrbiMed, a global healthcare investment firm. The facility includes $125 million of funded capital with an option to borrow up to an additional $75 million until June 30, 2027. This facility matures on July 31, 2030, and bears interest at a rate based upon the one-month secured overnight financing rate (SOFR) plus 6.50% per year, subject to a SOFR floor of 2.50% per year.

“We are excited to partner with OrbiMed, a leading global healthcare investment firm. We value their insight and financial backing, which supports our ability to pursue our near-term objectives and long-term growth plan,” Scott Leffler, chief financial officer of Myriad Genetics, said. “Between this credit facility and our cash and cash equivalents, we now have access to more than $200 million in capital to support the company’s growth strategy, which we will speak to in more detail on our upcoming second quarter earnings call.”

“We are pleased to partner with Myriad to support the company’s growth strategy,” Matthew Rizzo, general partner of OrbiMed, said. “We believe Myriad’s portfolio of diagnostic tests provide critical insights that enable healthcare providers to deliver better care to patients.”

The new credit facility with OrbiMed replaces Myriad’s previous ABL facility. The credit facility is secured by substantially all the assets of Myriad Genetics and its subsidiaries. Evercore served as exclusive financial advisor to Myriad Genetics on this transaction.

Previous Post

Hyperscale Data Enters into Agreement for Financing of Up to $100MM

Next Post

Republic Bank Adds New C-Suite Leaders

Related Posts

Advanced Power Closes $100M Corporate Credit Facility
Deal Announcements

Legacy Corporate Lending Provides $25MM Credit Facility to Digs

November 18, 2026
Advanced Power Closes $100M Corporate Credit Facility
Deal Announcements

Trinity Capital Provides $100MM in Debt Financing to Phononic

November 18, 2026
Deal Announcements

SLR Business Credit Provides $18.2MM Senior Secured Credit Facility to Central Valley Builders Supply

November 18, 2026
Deal Announcements

o15 Capital Partners Provides Unitranche Facility and Co-Investment to Support Bluestone Equity Partners

November 18, 2026
Deal Announcements

Salem Five Provides $6.1MM Credit Facility to American Petroleum

November 18, 2026
Deal Announcements

SG Credit Partners Provides Senior Debt Investment in Forager Project

November 18, 2026
Next Post

Republic Bank Adds New C-Suite Leaders

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

About Us

For over 50 years, RAM Holdings’ brands have led the commercial finance industry in publishing, talent development, research and events. ABF Journal’s audience is comprised of as many as 18,000 specialty finance industry executives, private equity investors, investment bankers, advisors, service providers and more.

Our Brands

  • Secured Research
  • Equipment Finance Originator
  • Monitor
  • Monitor Suite
  • Converge
  • STRIPES Leadership

 

Learn More

  • Advertise
  • Magazine
  • Contact Us

Newsletter

Driving specialty finance forward for decades with insights, recognition and deals. Sign up now.

SUBSCRIBE >>

© 2025 RAM Group Holdings - A Leading Commercial Finance Publishing Group For Over 50 Years

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • News
    • People
    • Economy
    • All News
  • Deals
  • Features
    • Articles & Insights
    • Resolving MCA Distress
    • Resolving Business Distress
  • Magazine
    • Magazine Issues
    • Nominations
  • Molloy Associates
    • Molloy Associates Senior Asset Based Lending Originator Location: Remote
  • Events
  • Advertise
  • Contact Us
Provider Directory >>

© 2025 RAM Group Holdings - A Leading Commercial Finance Publishing Group For Over 50 Years